JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, J.
Right arrow Articles by Yamamoto, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, J.
Right arrow Articles by Yamamoto, I.
Journal of Nuclear Medicine Vol. 42 No. 10 1476-1483
© 2001 by Society of Nuclear Medicine


Clinical Investigations

Expression of Multidrug Resistance Protein and Messenger RNA Correlate with 99mTc-MIBI Imaging in Patients with Lung Cancer

Jinshan Zhou, Kotaro Higashi, Yoshimichi Ueda, Yuko Kodama, Dachuan Guo, Fumiko Jisaki, Aya Sakurai, Tsutomu Takegami, Shogo Katsuda and Itaru Yamamoto

Departments of Radiology and Pathology and Division of Tropical Medicine, Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan

In vitro studies have shown that 99mTc-sestamibi (MIBI) is a transport substrate for the P-glycoprotein (Pgp) pump and the multidrug resistance–associated protein (MRP) pump. However, whether MRP and lung resistance protein (LRP) affect tumor accumulation and efflux of 99mTc-MIBI in lung cancer is not known. In this study, we explored whether Pgp and the other pumps, MRP and LRP, affect tumor accumulation and efflux of 99mTc-MIBI in lung cancer. Methods: Thirty-four lung cancer patients who underwent surgery were examined. Before surgery, 99mTc-MIBI SPECT was performed 15 min and 180 min after injection, and early uptake, delayed uptake (L/Nd), and washout rate (L/Nwr) of 99mTc-MIBI were obtained. Pgp, MRP, and LRP expression were investigated by immunohistochemistry. The messenger RNA (mRNA) level of Pgp, MRP, and LRP was determined by real-time reverse-transcription polymerase chain reaction. The lung cancer 99mTc-MIBI images were correlated with protein and mRNA expression. Results: The mean L/Nd of the Pgp (-) group was significantly higher than that of the Pgp (++) group (P = 0.0324). The Pgp (++) group had a higher L/Nwr than did the Pgp (-) group (P = 0.0269). The mean L/Nd of the Pgp mRNA low-expression group was significantly higher than that of the Pgp mRNA high-expression group (P = 0.0127). The Pgp mRNA high-expression group had a higher L/Nwr than did the Pgp mRNA low-expression group (P = 0.0825). No appreciable correlation was found between the lung cancer 99mTc-MIBI images and the expression of MRP or LRP on the level of protein or mRNA. Conclusion: These data suggest that an increased level of Pgp expression correlates with a low accumulation on delayed scans and a high L/Nwr of 99mTc-MIBI in lung cancer. Neither MRP nor LRP expression on the level of either protein or mRNA correlated significantly with tumor accumulation or efflux of 99mTc-MIBI in lung cancer.

Key Words: 99mTc-methoxyisobutylisonitrile • lung cancer • P-glycoprotein • multidrug resistance–associated protein • lung resistance protein




This article has been cited by other articles:


Home page
JNMHome page
J. Liu, A. Hajibeigi, G. Ren, M. Lin, W. Siyambalapitiyage, Z. Liu, E. Simpson, R. W. Parkey, X. Sun, and O. K. Oz
Retention of the Radiotracers 64Cu-ATSM and 64Cu-PTSM in Human and Murine Tumors Is Influenced by MDR1 Protein Expression
J. Nucl. Med., August 1, 2009; 50(8): 1332 - 1339.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J.-H. Wang, D. A. Scollard, S. Teng, R. M. Reilly, and M. Piquette-Miller
Detection of P-Glycoprotein Activity in Endotoxemic Rats by 99mTc-Sestamibi Imaging
J. Nucl. Med., September 1, 2005; 46(9): 1537 - 1545.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Kawata, M. Kanai, T. Sasada, S. Iwata, N. Yamamoto, and A. Takabayashi
Usefulness of 99mTc-Sestamibi Scintigraphy in Suggesting the Therapeutic Effect of Chemotherapy against Gastric Cancer
Clin. Cancer Res., June 1, 2004; 10(11): 3788 - 3793.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Z. Burak, J.-L. Moretti, O. Ersoy, U. Sanli, M. Kantar, F. Tamgac, and G. Basdemir
99mTc-MIBI Imaging as a Predictor of Therapy Response in Osteosarcoma Compared with Multidrug Resistance-Associated Protein and P-Glycoprotein Expression
J. Nucl. Med., September 1, 2003; 44(9): 1394 - 1401.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.